SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-10-034505
Filing Date
2010-06-16
Accepted
2010-06-16 15:26:48
Documents
1
Period of Report
2010-06-06

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c02479_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c02479_3x0.xml 3 6031
  Complete submission text file 0001209191-10-034505.txt   7999
Mailing Address P.O. BOX 110526 RESEARCH TRIANGLE PARK NC 27709
Business Address 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 919-316-6300
Talecris Biotherapeutics Holdings Corp. (Issuer) CIK: 0001405197 (see all company filings)

IRS No.: 202533768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 BROADWAY 32ND FLOOR NEW YORK NY 10271
Business Address 120 BROADWAY 32ND FLOOR NEW YORK NY 10271 212-238-3010
Grifols SA (Reporting) CIK: 0001438569 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34473 | Film No.: 10900538